Related Experiment Video
Updated: Apr 7, 2026

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
Published on: August 16, 2024
Engineered small extracellular vesicles as bioactive materials: Integrating engineering strategies for cargo loading
Hongtao Xu1, Rui Liu2, Hao Zhou1
1Department of Orthopedics, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, 210029, China.
Small extracellular vesicles (sEVs) are engineered bioactive materials for advanced therapeutics. These vesicles can be programmed for targeted drug delivery, enhancing regenerative medicine and oncology treatments.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Cell Biology
Background:
- Small extracellular vesicles (sEVs) possess unique membrane composition and nanoscale architecture.
- sEVs serve as a versatile platform for therapeutic engineering, acting as active carriers rather than passive ones.
Purpose of the Study:
- To review recent advances in engineering sEVs as programmable bioactive materials.
- To discuss the potential of engineered sEVs in regenerative medicine, oncology, and precision therapeutics.
Main Methods:
- Endogenous modulation of donor cells (genetic editing, priming, cytokine stimulation, hypoxic cues) for selective cargo packaging.
- Exogenous techniques (electroporation, sonication, extrusion) for controlled incorporation of therapeutics and genome-editing complexes.
- Surface modifications (Lamp2b-fusion scaffolds, aptamers, antibodies, click chemistry) for tissue tropism and extended circulation.
- Integration with nanomaterials, scaffolds, and microfluidic platforms for enhanced stability and scalability.
Main Results:
- Engineered sEVs demonstrate efficient loading, precise targeting, and functional integration with synthetic systems.
- Surface modifications improve sEVs' tissue tropism and circulation time.
- Integration strategies enhance sEV stability, scalability, and reproducibility.
Conclusions:
- Engineered sEVs represent a promising frontier at the intersection of biology and materials science.
- Programmable sEVs hold significant potential to revolutionize regenerative medicine, oncology, and precision therapeutics.
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Modified-Release Drug Delivery Systems: Site-Targeted
COP Coated Vesicles

